Skip to main content

Table 3 Comparison of neoadjuvant hormonal therapy on the outcome of laparoscopic radical prostatectomy

From: Neoadjuvant hormonal therapy is a feasible option in laparoscopic radical prostatectomy

References Period of NHT* (months) No. of patients Transfusion rate (%) PSM** rate (%) BCR*** rate after 2 years (%)
Rassweiler et al. [14]
 NHT group NA 42 46.0 NA NA
 non-NHT group - 138 NA NA NA
Gregori et al. [15]
 NHT group less than 3 21 NA NA NA
 non-NHT group - 59 NA NA NA
Brown et al. [7]
 NHT group less than 3 5 0 0 NA
 non-NHT group - 60 1.7 17.0 NA
Maldonado-Valadez et al. [16]
 NHT group 3.5 50 36.0 18.0 NA
 non-NHT group - 50 52.0 16.0 NA
Pu et al. [6]
 NHT group 3 25 32.0 12.0 NA
  8 19 31.2 10.5 NA
 non-NHT group - 11 36.4 45.5 NA
Our series
 NHT group 3 or less 47 2.12 27.7 27.7
  more than 3 25 4.00 28.0 4.00
 non-NHT group - 270 1.48 42.2 17.8
  1. Reviews of the impact of NHT prior to LRP on operative and postoperative parameters.
  2. NHT*: neoadjuvant hormonal therapy PSM**: positive surgical margin BCR***: biochemical recurrence.
  3. NA: not available PSM: positive surgical margin BCR: biochemical recurrence.